NPI: 1154372944 · MENOMONIE, WI 54751 · Critical Access Hospital · NPI assigned 05/15/2006
Authorized official BORTNEM, MARK controls 20+ related entities in our dataset. Read more
| Authorized Official | BORTNEM, MARK (CFO) |
| NPI Enumeration Date | 05/15/2006 |
Other providers sharing the same authorized official: BORTNEM, MARK
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 46,475 | $943K |
| 2019 | 44,363 | $1.18M |
| 2020 | 41,647 | $1.15M |
| 2021 | 56,351 | $1.57M |
| 2022 | 52,451 | $1.70M |
| 2023 | 55,561 | $1.93M |
| 2024 | 47,649 | $1.46M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 96361 | Intravenous infusion, hydration; each additional hour | 3,919 | 3,281 | $1.49M |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 10,939 | 7,238 | $1.37M |
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 6,960 | 5,475 | $1.14M |
| 99284 | Emergency department visit for the evaluation and management, high severity | 8,339 | 5,925 | $985K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 21,581 | 16,502 | $505K |
| 70450 | Computed tomography, head or brain; without contrast material | 2,092 | 1,795 | $438K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 2,110 | 1,850 | $430K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 1,795 | 1,615 | $314K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 12,783 | 5,481 | $283K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 1,668 | 1,209 | $269K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 1,046 | 951 | $225K |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 14,332 | 10,126 | $159K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 4,101 | 3,736 | $118K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 3,807 | 3,396 | $105K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 20,931 | 16,836 | $90K |
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 9,807 | 6,849 | $81K |
| 80053 | Comprehensive metabolic panel | 11,220 | 9,378 | $80K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 1,284 | 920 | $79K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 1,697 | 1,569 | $78K |
| 87631 | 812 | 712 | $69K | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 4,623 | 2,291 | $68K |
| 80048 | Basic metabolic panel (calcium, ionized) | 11,865 | 10,077 | $65K |
| 84443 | Thyroid stimulating hormone (TSH) | 6,313 | 5,755 | $64K |
| 90834 | Psychotherapy, 45 minutes with patient | 901 | 707 | $58K |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | 3,473 | 1,837 | $56K |
| 99215 | Prolong outpt/office vis | 4,600 | 3,398 | $54K |
| 71275 | Computed tomographic angiography, chest, with contrast material | 234 | 221 | $51K |
| 97162 | 1,717 | 1,635 | $51K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1,524 | 1,362 | $48K |
| 80061 | Lipid panel | 5,202 | 4,744 | $47K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 630 | 381 | $41K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 5,682 | 5,101 | $39K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | 130 | 104 | $39K |
| 87480 | 2,597 | 2,209 | $39K | |
| 87660 | 2,597 | 2,209 | $38K | |
| 87510 | 2,597 | 2,209 | $38K | |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 161 | 146 | $37K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 1,326 | 1,026 | $36K |
| 83036 | Hemoglobin; glycosylated (A1C) | 6,169 | 5,651 | $34K |
| 71046 | Radiologic examination, chest; 2 views | 3,141 | 2,750 | $33K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | 174 | 153 | $33K |
| 73630 | 1,068 | 881 | $29K | |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 439 | 382 | $28K |
| 97161 | 753 | 707 | $28K | |
| 72125 | Computed tomography, cervical spine; without contrast material | 446 | 390 | $26K |
| 66984 | Extracapsular cataract removal with insertion of intraocular lens prosthesis | 51 | 25 | $26K |
| 81025 | 4,119 | 3,596 | $26K | |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | 124 | 108 | $23K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 4,791 | 3,724 | $22K |
| 84484 | 2,855 | 2,365 | $22K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 653 | 493 | $21K |
| 83605 | 3,481 | 2,914 | $20K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 1,245 | 1,152 | $18K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 3,799 | 2,857 | $18K |
| 80306 | 1,283 | 1,100 | $17K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1,262 | 1,178 | $15K |
| 81001 | 6,976 | 6,116 | $14K | |
| 83690 | 3,405 | 2,854 | $14K | |
| 85610 | 6,115 | 3,596 | $12K | |
| 80050 | General health panel | 444 | 390 | $12K |
| 83880 | 929 | 834 | $11K | |
| 83735 | 3,005 | 2,358 | $11K | |
| 90837 | Psychotherapy, 53 minutes with patient | 153 | 101 | $10K |
| 82077 | 1,127 | 892 | $9K | |
| 76830 | Ultrasound, transvaginal | 113 | 97 | $9K |
| 82728 | 883 | 809 | $9K | |
| 85027 | 2,238 | 1,921 | $9K | |
| 86140 | 2,757 | 2,343 | $9K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | 133 | 112 | $9K |
| 87103 | 1,117 | 966 | $8K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 6,524 | 5,370 | $8K |
| 87040 | 2,111 | 967 | $7K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 2,479 | 2,229 | $7K |
| 81003 | 4,464 | 3,987 | $7K | |
| 82947 | 2,469 | 2,084 | $7K | |
| 85379 | 1,087 | 964 | $6K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | 114 | 109 | $6K |
| 82570 | 1,929 | 1,605 | $6K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 180 | 168 | $5K |
| 84702 | 467 | 365 | $5K | |
| 82043 | 1,573 | 1,410 | $5K | |
| 82565 | 1,589 | 1,292 | $5K | |
| 73610 | 273 | 226 | $5K | |
| 73030 | 209 | 184 | $5K | |
| 82803 | 416 | 356 | $5K | |
| 86850 | 1,436 | 1,231 | $5K | |
| 80143 | 424 | 349 | $4K | |
| 82948 | 1,630 | 886 | $4K | |
| 80179 | 373 | 306 | $4K | |
| 82248 | 1,421 | 1,200 | $4K | |
| 99203 | Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 250 | 169 | $3K |
| 71045 | Radiologic examination, chest; single view | 2,515 | 2,165 | $3K |
| 73564 | 184 | 153 | $3K | |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | 119 | 40 | $3K |
| 97535 | Self-care/home management training, each 15 minutes | 417 | 274 | $3K |
| 87077 | 1,041 | 956 | $3K | |
| 85018 | 1,590 | 1,427 | $3K | |
| 36415 | Collection of venous blood by venipuncture | 14,565 | 11,951 | $2K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 761 | 696 | $2K |
| 97597 | 154 | 38 | $2K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 102 | 95 | $2K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 102 | 95 | $2K |
| 90715 | 149 | 139 | $2K | |
| 84460 | 572 | 430 | $2K | |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | 24 | 17 | $2K |
| 87186 | 826 | 752 | $2K | |
| 93976 | 22 | 13 | $2K | |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | 644 | 568 | $2K |
| 96375 | Therapeutic injection; each additional sequential IV push | 3,336 | 2,729 | $2K |
| 84450 | 437 | 328 | $1K | |
| Q3014 | Telehealth originating site facility fee | 345 | 291 | $1K |
| 86901 | 772 | 659 | $1K | |
| 86900 | 772 | 659 | $1K | |
| 99442 | 98 | 94 | $1K | |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | 18 | 13 | $1K |
| 88142 | 39 | 39 | $970.47 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 3,231 | 2,646 | $943.46 |
| 91322 | 169 | 163 | $911.32 | |
| 83550 | 158 | 142 | $821.42 | |
| 83540 | 182 | 166 | $699.19 | |
| 72100 | 19 | 14 | $689.57 | |
| 36416 | 2,722 | 1,515 | $686.25 | |
| 90686 | 602 | 583 | $608.14 | |
| 99443 | 34 | 34 | $592.27 | |
| 73110 | 16 | 15 | $586.15 | |
| 73502 | 30 | 28 | $484.38 | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | 12 | 12 | $459.60 |
| 90662 | 445 | 434 | $428.48 | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 62 | 52 | $428.13 |
| 83655 | 27 | 25 | $391.99 | |
| J7030 | Infusion, normal saline solution , 1000 cc | 1,046 | 865 | $384.54 |
| 84550 | 160 | 147 | $365.11 | |
| 73562 | 16 | 12 | $340.63 | |
| 73080 | 13 | 12 | $326.41 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 2,423 | 1,326 | $288.60 |
| 90480 | 165 | 160 | $264.10 | |
| 93971 | 17 | 15 | $192.99 | |
| 85652 | 99 | 94 | $180.42 | |
| 82950 | 39 | 38 | $173.90 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 988 | 822 | $92.19 |
| 0764T | 186 | 134 | $76.08 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 2,007 | 1,594 | $74.08 |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 173 | 155 | $73.13 |
| 84439 | 12 | 12 | $70.14 | |
| 84132 | 30 | 25 | $69.57 | |
| 86308 | 15 | 12 | $54.06 | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 18 | 12 | $51.58 |
| 0004A | 33 | 28 | $50.31 | |
| 84156 | 15 | 12 | $45.89 | |
| 90656 | 36 | 36 | $41.55 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 233 | 169 | $34.74 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 421 | 313 | $33.66 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 785 | 523 | $13.30 |
| 90677 | 59 | 55 | $13.23 | |
| J7120 | Ringers lactate infusion, up to 1000 cc | 32 | 27 | $11.64 |
| J3490 | Unclassified drugs | 292 | 211 | $10.47 |
| 90472 | Immunization administration, each additional vaccine (list separately) | 14 | 12 | $10.08 |
| J2795 | Injection, ropivacaine hydrochloride, 1 mg | 292 | 122 | $9.33 |
| 0064A | 31 | 31 | $4.05 | |
| J2704 | Injection, propofol, 10 mg | 29 | 14 | $3.81 |
| 0124A | 58 | 56 | $3.69 | |
| 0054A | 60 | 58 | $1.95 | |
| A9270 | Non-covered item or service | 1,792 | 1,612 | $0.00 |
| G0008 | Administration of influenza virus vaccine | 880 | 861 | $0.00 |
| V2632 | Posterior chamber intraocular lens | 32 | 29 | $0.00 |
| 92136 | 13 | 13 | $0.00 | |
| 96376 | 60 | 53 | $0.00 | |
| 93000 | 16 | 15 | $0.00 | |
| J1170 | Injection, hydromorphone, up to 4 mg | 38 | 26 | $0.00 |
| J1040 | Injection, methylprednisolone acetate, 80 mg | 15 | 15 | $0.00 |
| G0009 | Administration of pneumococcal vaccine | 39 | 39 | $0.00 |
| 87070 | 27 | 26 | $0.00 | |
| 0134A | 19 | 19 | $0.00 | |
| 00142 | 27 | 26 | $0.00 | |
| J2060 | Injection, lorazepam, 2 mg | 21 | 13 | $0.00 |
| J0697 | Injection, sterile cefuroxime sodium, per 750 mg | 12 | 12 | $0.00 |
| J8499 | Prescription drug, oral, non chemotherapeutic, nos | 69 | 55 | $0.00 |
| G8979 | Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | 110 | 105 | $0.00 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 49 | 38 | $0.00 |
| G8978 | Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals | 93 | 89 | $0.00 |
| J3475 | Injection, magnesium sulfate, per 500 mg | 14 | 13 | $0.00 |